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Abstract
Background
Buruli Ulcer (BU) is a neglected tropical disease caused by Mycobacterium ulcerans. For-
mer BU patients may experience participation restrictions due to physical limitations, stig-
matization and other social factors. A scale that measures participation restrictions among
children, who represent almost half of the affected population, has not been developed yet.
Here, we present the development of a scale that measures participation restrictions in for-
mer BU paediatric patients, the psychometric properties of this scale and the scales’ results.
Methods
Items were selected and a scale was developed based on interviews with health care work-
ers and former BU patients in and around the BU treatment centre in Lalo, Benin. Construct
validity was tested using six a priori formulated hypotheses. Former BU patients under 15
years of age who received treatment in one of the BU treatment centres in Ghana and Benin
between 2007–2012 were interviewed.
Results
A feasible 16-item scale that measures the concept of participation among children under
15 years of age was developed. In total, 109 (Ghana) and 90 (Benin) former BU patients
were interviewed between 2012–2017. Five construct validity hypotheses were confirmed of
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which 2 hypotheses related to associations with existing questionnaires were statistically
significant (p<0.05).
In Ghana 77% of the former patients had a Paediatric Participation (PP) scale score of 0
compared to 22% in Benin. More severe lesions related to BU were seen in Benin. Most of
the reported participation problems were related to sports, mainly in playing games with oth-
ers, going to the playfield and doing sports at school.
Conclusion
The preliminary results of the PP-scale validation are promising but further validation is
needed. The developed PP-scale may be valid for use in patients with more severe BU
lesions. This is the first research to confirm that former BU patients under 15-year face par-
ticipation restrictions in important aspects of their lives.
Author summary
Buruli Ulcer is a neglected tropical disease caused by infection with Mycobacterium ulcer-
ans. While treatment has largely improved, former BU patients may experience participa-
tion restrictions after treatment, due to physical limitations, stigmatization or other social
factors.
With more than half of the BU patient population in Africa being children, a scale that
measures participation restrictions among former paediatric BU patients is relevant but
has not been developed yet. Here, we present a scale that measures participation restric-
tions among former BU patients under the age of 15 year that is suitable for low-income
settings. The 16-item scale was developed in Benin and tested in both Ghana and Benin.
The scale shows good performance and may be used for several diseases that occur in sim-
ilar settings and result in disabilities (both physical and/or social).
Introduction
Buruli Ulcer (BU), caused by infection with Mycobacterium ulcerans (M. ulcerans) is a
neglected tropical disease that has been reported in 33 countries, predominantly tropical and
subtropical regions, but is mostly prevalent in sub-Saharan countries [1]. In 2016, almost 80%
of all new BU cases were reported in West Africa, mainly Coˆte d’Ivoire, Ghana, Benin, and
Nigeria [2]. Recently, an increase in both the spread of BU cases and the number of severe
cases in South-eastern Australia has been noticed [3]. Compared to the population distribution
of BU cases in West-Africa, where 48% of BU patients are under 15 years of age, in that study
the median age was 58 years (IQR 38;74), and only 10% was under the age of 15 years [3].
M. ulcerans infection produces a toxin that leads to destruction of the skin and soft tissue.
The proportion of affected body parts and categories of disease differ per geographical region.
In the region of Western Africa, the limbs are the most frequently affected body parts with
55% of lesions on the lower limbs, 35% on the upper limbs and only 10% on other parts of the
body [4]. Treatment consists of wound care and antibiotic treatment with rifampicin/strepto-
mycin or rifampicin/clarithromycin [5]. Surgery was once the mainstay of treatment of BU,
but a recently published trial showed that even large ulcers can heal with antibiotics and
wound care alone [6]. BU lesions are categorized based on severity: Category I for single small
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lesions<5cm in diameter, Category II for single non-ulcerative and ulcerative plaque and
oedematous lesions with a diameter of 5-15cm, and category III for lesions>15 cm in diame-
ter, multiple lesions, lesions at critical sites as head and neck region and genital region, dissem-
inated and mixed forms as osteitis, osteomyelitis and joint involvement [5].
Although the mortality from BU is low, it frequently leads to disability such as restriction in
range of motion of joints contributing to functional limitations [7]. Apart from functional lim-
itations, stigmatization and economic burden may impact social life of (former) patients, such
as school dropout and unemployment [8,9]. A qualitative study showed a high impact of BU
on social life and maintenance of work/school, and a need among former patients with BU for
support and counselling on how to deal with economic and social burden as a result of BU
[10].
To measure the impact of disease on an individual and their environment, the WHO estab-
lished the International Classification of Function, Disability and Health (ICF) criteria that
describe disabilities in terms of impairments, activity limitations and participation restrictions
[9]. Participation restriction is defined as ‘any problem an individual may experience in
involvement in nine life domains such as learning and self-care, domestic life, interpersonal
interactions and relationship and social and civic life’ [9]. Based on this definition a participa-
tion scale (P-scale) was developed to measure perceived restrictions in these life situations
among adult individuals with disabilities in low and middle-income countries [11]. The P-
scale consists of 18 items and has been used to measure participation restrictions among for-
mer patients with BU, leprosy, poliomyelitis or spinal cord injuries [11,12].
The P-scale among former adult BU patients demonstrated long term participation restric-
tions mainly among patients with large lesions [12,13]. To our knowledge, the P-scale has only
been used in adults. In sub-Saharan Africa, almost half of the BU patients are children under
the age of 15 years, but a scale to evaluate participation problems in this group does not exist
[1,5]. This study focuses on the development of a participation scale suitable for former BU
patients under 15 years of age (Paediatric Participation scale: PP-scale).
The aim of this study is to develop a scale to measure participation problems in children
after treatment for BU, to analyse the psychometric properties of this scale as used in Ghana
and Benin and to present scale results.
Methods
Requirements were set for different participation domains that needed to be measured, as
described by the ICF [9]. The development process consisted of three phases;
Phase I: Item collection and formulation of first draft questionnaire;
Phase II: Item reduction analysis and content validity of the draft scale;
Phase III: Psychometric testing and analysis [10].
Phase I: Item collection and formulation of first draft questionnaire
Study participants. For the first phase of the study medical specialists, teachers, other
community workers, chiefs and parents of former patients were included and interviewed for
item collection at the BU Treatment Centre in Lalo, Benin and in its surrounding villages
based on purposive sampling.
Scale development process. During the interviews, the participants were asked to imagine
a boy/girl aged 3 years living in the village and answer five sections of questions related to their
participation.
In the first section, daily activities were questioned, such as the estimated age a child starts
eating independently, age when a child starts collecting water, age when a child participates in
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ceremonies, age the child starts with household responsibilities. Secondly, participants were
asked to imagine a young boy (aged between 6–12) who is affected with BU and just finished
treatment. Questions on their knowledge of the disease, cause of disease, treatment and conse-
quences of BU were asked, as well as their thoughts on the way others in the community view
(former) BU patients. In the third section, participants were again asked to imagine the same
boy at school. Questions on the responsibilities and barriers the child may face at school were
asked (e.g. if the disease would influence the child’s opportunity to participate in class, to par-
ticipate in school-related activities, establish relationship with peers/teachers). In the fourth
section, responsibilities of the child in household activities were questioned, as well as barriers
the child may face as a result of the disease. In the last section, questions with regard to com-
munity participation were asked (e.g. if the child has similar opportunities as other children of
the same age to participate in community events, what could be potential barriers, religious
constrains etc). Based on the responses of the participants in these interviews, general practices
and potential barriers with relation to BU were identified. Relevant items were collected and
questions were formulated to be tested in phase II. The items were aimed to be understandable
from the age of 5 year and therefore needed to be simple.
Peer comparison concept & response options. Roles and participation may differ
between individuals within the community and it can be difficult for participants to com-
pare situations before and after their disease. Therefore, Brakel et al (2006) used in the P-
scale the ‘peer comparison concept’ to partly overcome these challenges [11]. For the PP-
scale the ‘peer comparison concept’ was also used. Responders were asked to compare
themselves with their peers, and items were formulated accordingly (e.g. Can you go to the
market just like the other children do?). The response options for the PP-scale are similar to
the response options of the P-scale (Yes/ Sometimes/ No). If the answer was ‘Sometimes’ or
‘No’, the responders were asked to rate the importance of this limitation using a 5-item
Likert scale. To each response option a numeric value is attached to calculate the total sum
score. The response options are: ‘Yes (0)’; ‘No problem (1)’ (the participant does not experi-
ence a participation restriction; ‘A little bit important (2)’ (the participant experiences some
participation restriction and considers it a medium important restriction); ‘Important (3)’
(the participant has difficulties with the item and considers it an important restriction); ‘Very
important (5)’ (if the participant is not able to perform the item and considers it highly impor-
tant). If the item was not relevant to the participant, the participant could answer with
either ‘Irrelevant/I don’t want to/I don’t have to (0)’(if the question is not relevant for the
participant) or ‘Not specified, not answered (0)’ (if the question does not apply to the partici-
pant or was not answered, e.g. participant is too young for an activity). The total sum-score is
calculated by adding up the scores of all individual items. The lowest PP-scale sum score
possible is 0 and the maximum PP-scale sum score possible is 80, indicating the poorest
score.
Phase II: Item reduction analysis and content validity of the draft scale
Study participants. After collecting items of the paediatric participation scale, former
patients under 15 years of age were included and invited to participate in the pre-testing of the
collected items at the BU Treatment Centre in Lalo, Benin and in its surrounding villages
based on convenience sampling. Information on socio-economic characteristics (e.g. village,
religion, profession, type of housing, access to water, access to electricity, stable income, dis-
ease insurance. Information on the disease and treatment (date of diagnosis, duration of dis-
ease, type of treatment, category of lesion, treatment outcome, presence and position of BU
related lesions) was retrieved from medical records.
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Scale development process. First the understandability of the questions and response
options were tested (Phase II.1) Secondly, items were tested for endorsement, discrimination
ability and correlation with sociodemographic factors (Phase II.2). To test for endorsement,
items with a positive response of less than 10% or over 90% were excluded. Items that showed
a strong correlation with socio-demographic variables were excluded. After elimination of
items, a draft questionnaire was composed to be tested in phase III.
Phase III: Psychometric testing and analysis
Study participants. For the third phase former patients were identified using patients’
records kept by the BU health-care workers of the hospital/treatment centre in Agogo, Ghana
and Allada/Lalo, Benin. In Ghana, the patients’ records proved to be incomplete. Therefore,
sampling strategy was adjusted and convenience sampling at schools located within the reach
of the hospital were performed. Community volunteers were asked to identify former patients
at the schools.
In Benin, convenience sampling based on the accessibility of village of origin of the partici-
pant and the number of former patients living in the village was used. Criteria for inclusion as
former patient was being diagnosed with BU (confirmed by PCR) in one of the treatment hos-
pitals between 2007–2012, having finished treatment at least three months earlier and being
below age of 15 years at the time of the interview. Exclusion criteria were not being able to give
informed consent and being <5 years old. Participant characteristics, treatment (antibiotics/
surgery), category of lesion, and joint involvement were collected from the medical records if
available. Community controls were selected using frequency matching based on age (+5/-5
years, minimum age of 5 years), gender and geographical location. All patients and controls
were interviewed in Ghana and Benin between November 2015 and May 2017.
Scale development process. In this phase, the questionnaire was tested for construct
validity, inter-interviewer reliability (1-month interval), and known groups validity (discrimi-
nation between patients and controls) in Ghana and Benin.
Construct validity
To test the ability of the PP-scale to measure the intended social construct of participation, 6 a
priori hypotheses were formulated similar to the study by the Zeeuw et al. (2014) but adjusted
for children (box 1). In total 5 out of 6 of the hypotheses need to be confirmed to positively
rate construct validity [11].
Hypothesis 1: Former BU patients under 15 years with category III lesions have higher PP-
scale scores than those with category I & II lesions. (In de Zeeuw et al, hypothesis number one
was based on the variable ‘visible deformities’. Since this variable was not reliably scored in our
study population, we replaced this hypothesis with ‘category III lesions’, being another indica-
tor predicting long term problems).
Hypothesis 2: Former BU patients under 15 years with a joint involved have significantly
higher PP-scale scores than those without.
Hypothesis 3: Former BU patients under 15 years who have stopped attending school have
significantly higher PP-scale scores than those who continued attending school.
Hypothesis 4: A positive correlation (0.4� r� 0.8) exists between the PP-scale sum scores
and the Buruli Ulcer Functional Limitation Scores (BUFLS).
Hypothesis 5: A positive correlation (0.4� r� 0.8) exists between the PP-scale sum scores
and the Children’s Dermatology Life Quality Index (CDLQI) scores.
Hypothesis 6: A high level of agreement (Cohen’s κ� 0.7) exists between the PP-scale sum
scores of former patients with BU and their relatives [12].
Paediatric participation scale and Buruli Ulcer
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Reliability
The inter observer reliability was calculated in order to find the amount of agreement and
error between different interviewers. A retest of the PP-scale within one month after first
assessment was performed in Ghana by an interviewer other than the initial tester. The inter-
class correlation coefficient (ICCagreement) was used to analyse the inter-observer reliability. An
ICC score of 0.7 and a minimum of 50 observations is considered as minimum to positively
rate reliability [14].
Floor and ceiling effects
Floor and ceiling effects were considered present if >15% of participants scored lowest (0) or
highest (80) possible score on the PP-scale [14].
Discrimination
To test discriminative value of the instrument, former patients and healthy controls were inter-
viewed. Questions were classified as being discriminative if there was a significant difference
(p<0.05) in PP-scale sum scores between participants and healthy controls.
Questionnaires
The Buruli Ulcer Functional Limitation Score (BUFLS) and the Children’s Dermatology Life
Quality Index (CDLQI) were used to test construct validity of the PP-scale.
BUFLS: The BUFLS measures functional limitations among (former) BU patients. The
questionnaire covers four areas of activity and corresponds to 19 items of day-to-day activities.
The four areas are preparation of food/eating (four questions), clothing/personal care taking
(three questions), working (five questions), and mobility (seven questions). Responses are
scored as 0‘easy/normal, 1‘with difficulties’ and 2‘not possible at all’. The total score is calcu-
lated as sum of individual scores divided by the maximal score of all applicable items, multi-
plied by 100. Possible values range from 0–100 percent, a score of 0 implies no functional
limitations and a higher score means more functional limitations [15,16].
CDLQI: The CDLQI measures the impact of skin disease on the lives of children aged
from 4 to 16 years. The 10 items cover six areas of daily activities including symptoms and
feelings, leisure, school or holidays, personal relationships, sleep, and treatment. The ques-
tions are based on the preceding week to minimize recall bias. Each item is answered on a
4-point Likert scale scored from 0 to 3. These are added to give a minimum score of 0 and
maximum score of 30. A higher CDLQI score indicates greater degree of Quality of Life
impairment [17]. The CDLQI is a well validated tool used in 28 countries worldwide,
including low-income countries as Ethiopia and Ghana [24]. It was used previously in a
study on the Quality of Life (QoL) among 54 former BU patients in Ghana but has not been
validated in Ghana before [24].
Procedure
Before testing the questionnaire in PHASE III, all items of the draft PP-scale were translated
from English to French and backwards with the help of well-trained translators. This included
thorough discussion of the interpretation of questions at the start of data collection and at sev-
eral meetings during data collection. We worked with the same translators during the entire
study period. Former patients were interviewed in their local language (Twi in Ghana, Fon in
Benin) but this was not written down because these languages are not often written down or
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read. Native speakers discussed the items with the translators to ensure correct translation of
the items.
To ensure privacy during the interviews, we tried to find quiet places, either at school or at
home, to conduct the interviews. The other two questionnaires (BULFS, CDLQI) are available
in English and French.
Ethical consent
The Medical Ethical Review committees of the Kwame Nkrumah University of Science
and Technology; School of Medical Sciences, Komfo Anokye Teaching Hospital in Ghana
(ref: CHRPE/RC/127/12) and Ministry of Health in Benin (ref: No012/MS/DC/SGM/
DFR7CNERS/SA) approved the study. Before each interview the procedure was explained and
written informed consent was obtained from both the participants and parent or caretaker, as
by definition, all participants were under the age of 15. If the participant was not able to read,
the consent form was read aloud by the interpreter. If the participant was not able to write but
agreed to participate, a fingerprint (thumb print) was used. No incentives were paid to the par-
ticipants, only small goods such as snacks were given to the participants.
Statistics
Data was analysed using STATA version 15.1. Descriptive statistics were used to describe base-
line characteristics. Correlation of the items with sociodemographic variables was tested using
Spearman’s rho. The Mann-Whitney U test was used to analyse potential differences between
PP-scale scores by category of lesion, joint involvement, and socio-economic characteristics.
Spearman’s rho was calculated to assess the strength of association between PP-scale score and
scores of the BUFLS and CDQLI questionnaires. Cohen’s kappa and Spearman’s rho were
used to compare the total PP-scale scores as reported by the participant and those reported by
the accompanying relative. Rationale for use of the kappa agreement instead of another corre-
lation test was that parents are likely to rate the importance of the included items differently.
Inter observer reliability was assessed using the intraclass correlation coefficient (ICC) and
Bland-Altman plot analysis of agreement (95% CI). Discrimination ability between patients
and controls was tested using Mann-Whitney U.
Results
Phase I: Item collection and formulation of first draft questionnaire
Study population. For the scale development, a total of 49 persons were questioned in
Benin; 7 teachers, 3 village chiefs, 1 nurse, 1 medical researcher, 4 medical assistants, 4 relatives
of children with BU, 4 former adult patients suffering of BU, 18 former paediatric patients and
7 other adults.
Scale development process. After interviews with all informants, a list of items was com-
posed in close collaboration with the informants. All items were checked for interpretability
and content validity, resulting in 25 items that were formulated in French and English (S1
Appendix).
Phase II: Item reduction analysis and content validity of the draft scale
Study population. In November 2015, 15 former BU patients younger than 15 years of
age were interviewed to test the comprehensibility of the questions and the response options.
The (mean(sd) age was 11.3 (± 0.57) years and 6 were male (Phase II.I).
Paediatric participation scale and Buruli Ulcer
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In November and December 2015, 46 former BU patients under 15 years of age were inter-
viewed to test endorsement, discrimination ability and sociodemographic correlation of the
questionnaire. The mean (SD) age was 10.8 ((± 0.34)), 24 (52%) were male, and 26 (57%)
attended primary school (Phase II.2).
Scale development process. Phase II.1: Response options were tested among the 15 for-
mer BU patients and minor changes were made to increase the comprehensiveness.
Phase II.2: Testing for endorsement, discrimination ability, sociodemographic correlations
resulted in the elimination of 9 items. Two items (Q1 & Q17) were eliminated due to a single
correlation with respectively age and the location of the lesion. Seven items were eliminated
due to a very weak level of internal consistency (Q8, Q9, Q12, Q13, Q14, Q15, Q17, Q18). The
final questionnaire consisted of 16 items (Q2, Q3, Q4, Q5, Q6, Q7, Q10, Q11, Q16, Q19 t/m
25) and this questionnaire was tested in PHASE III (S2 Appendix).
Phase III: Psychometric testing and analysis
Study population. In Benin, 679 former paediatric BU patients in Benin were identified
using medical records of the years 2005–2012. Of the 679 identified former patients, 289 had
reached an age less than 15 at time of the interview and were therefore not eligible. In total 90
(31%) former paediatric BU patients were interviewed in their villages between February 2016
and May 2017 in Benin.
In Ghana, 109 former paediatric BU patients were interviewed at schools located within
region of the hospital between February 2016 and May 2017. Of the total 199 participants, 113
(57%) were male and the mean(sd) age at time of data collection was 10.5 (± 0.17). Most of the
former patients in Ghana had category I lesions at start of treatment and the majority of for-
mer patients in Benin had category II lesions at start of treatment. Former BU patients in
Ghana had a median (IQR) PP-scale score of 0 (0–2) while former patients in Benin had a
median (IQR) PP-scale score of 6 (2–14) (Table 1).
PP-scale testing: Construct validity, reliability, and discrimination of the draft PP-Scale
were tested.
Validity
Hypothesis 1: Former patients with category III lesions have higher PP-scale scores (n = 33,
median (IQR) = 3(0;16)) than those with category I or II lesions (n = 146, median (IQR) = 0
(0;6) (z = -1.79, p = 0.073).
Hypothesis 2: Former patients with a joint involved have higher PP-scale scores (n = 46,
median (IQR) = 1(0;11)) than those without (n = 153, median (IQR) = 0(0;7) (z = -0.86,
p = 0.39)).
Hypothesis 3: In Benin, the PP-scale score of patients who dropped out from school after
treatment due to BU (n = 12, median (IQR) 9(5;18)) is higher than the score of children who
attended school after treatment (n = 48, median (IQR) 3(0;12) (z = -1.82; p = 0.070)).
Hypothesis 4: A positive correlation of 0.552 (Spearman, n = 198, p< 0.001) exists between
the PP-scale sum scores and the BUFLS sum scores. The BUFLS had a median (IQR) score of
0 (0;7.9) in Benin and 0 (0;10.5) in Ghana. The BUFLS was more than 0 (indicating a func-
tional limitation) in 47.2% (n = 42) in Benin and 39.5% (n = 43) in Ghana.
Hypothesis 5: A positive correlation of 0.638 (Spearman, n = 196, p< 0.001) was found
between the PP-scale sum scores and the CDLQI scores. The CDQLI had a median (IQR) of 8
(5;10) in Benin and 3 (0.5;7) in Ghana;
Hypothesis 6: A Cohen kappa score of 0.248 (N = 62, 95% CI 0.20;0.55) patients and their
relatives was found. A weak correlation of 0.343 (Spearman, n = 62, P<0.01)) was found
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between the PP-scale sum scores of former patients with BU and the score as reported by their
relatives (S3 Appendix).
Inter-observer reliability
To test inter-observer reliability, the scores of 32 participants were reassessed. An ICC score of
0.379 (95% CI (0.04;0.65)) was found. This number of observations is too small to positively
rate inter-observer reliability (S3 Appendix–Bland-Altman plot: mean difference = 2.5 (95%
CI (-1.2;6.3); sd of difference: 10.6, limits of agreement (reference range for difference):
[-18.7;23.8]. The smallest detectable change (SDC) based on the 32 measurements for reliabil-
ity analysis is 21.1 [14]. This value is larger than the considered minimal important change
(MIC) and further validation with a sufficient sample size is needed.
Floor and ceiling effects
Floor effects were present. In Benin, 22% (n = 20) of the participants scored 0 on the PP-scale
and in Ghana 71% (n = 77) (X2 = 46.25, p< 0.001). None of the participants had a maximum
score of 80 points, therefore no ceiling effects were present.
Discrimination
To test for discriminative value of the instrument, 79 healthy controls were interviewed and
the responses were compared with patient responses. Age and gender did not differ signifi-
cantly between former BU patients and controls. Former patients had a higher median (IQR)
PP-score (1(1;9)) than healthy controls (0(0;0)) (Wilcoxon rank sum z = 6.96, p< 0.0001).
Participation restrictions
Former BU patients from Benin reported more participation restrictions compared to former
patients from Ghana. In both countries, most of the reported problems were related to sports,
mainly in playing games with others (Q12), going to the playfield (Q10) and doing sports at
Table 1. Baseline characteristics of study population (Phase III).
N = 109 N = 90 N = 199
PLACE OF INCLUSION Ghana Benin Total
AGE AT TIME OF INCLUSION (MEAN(SD)) 11.0 (2.4) 9.9 (2.4) 10.5 (0.17)
MALE N (%) 63 (58) 50 (40) 113 (57)
CATEGORY LESION N (%)� I
II
III
65 (59.6)
24 (22.0)
20 (18.4)
25 (35.7)
32 (45.7)
13 (18.6)
90 (50.3)
56 (31.3)
33 (18.4)
JOINT INVOLVEMENT YES (%) 26 (24) 20 (22) 46 (23)
IN SCHOOL AFTER TREATMENT YES�� (%) 94 (86.2) 48 (53.3) 142(71.4)
SCHOOL DROP-OUT DUE TO BU YES (%) 2 (2) 12 (13) 22 (11.1)
PP-SCALE SCORE MEDIAN(IQR) [RANGE] (%-PP-SCALE SCORE ZERO) 0 (0;2) [0–50] (70%) 6 (2;14) [0–59] (22%) 1 (0;9) [0–59]
(48%)
BUFL SCORE (MEDIAN(IQR) 0 (0;7.9) 0 (0;10.5) 0(0;3)
CDLQI SCORE (MEDIAN(IQR) 3 (0.5;7) 8 (5;10) 6(2;9)
�Category of lesion missing for 20 patients in Benin and for 8 patients in Ghana
�� Information on school attendance was missing for 4 patients in Benin. Abbreviations: BU = Buruli Ulcer; IQR = Inter Quartile Range; PP = Paediatric Participation;
BUFL = Buruli Ulcer Functional Limitations; CDLQI = Children’s Dermatology Life Quality Index
https://doi.org/10.1371/journal.pntd.0007273.t001
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school (Q13). In Benin, former patients experienced also problems with participation in
domestic life and religious ceremonies, while in Ghana this was very rare. S4 Appendix sum-
marizes the scores per question (S4 Appendix).
In Benin, 44% (38/86) of the patients interviewed did not attend school, 32% (12/38) of
whom stopped attending school because of BU. In Ghana, 14% (15/108) did not go to school,
of whom 13.3% (2/15) dropped out of school because of BU. Other reasons for not attending
school were poverty, lack of motivation to go to school, or other unknown reasons.
Discussion
The aim of this study was to develop and test a scale that measures participation restrictions
among former Buruli Ulcer patients under the age of 15. We developed a scale with feasible
items that measures the concept of participation among children under the age of 15 but
requires further testing on the validity and applicability of the scale.
We faced several constrains when testing the validity of the instrument we developed. In
total, 5 out of 6 a priori set hypotheses could be confirmed but only 2 showed statistically sig-
nificant associations (p<0.05). The results were in the direction as predefined, but due to a
low percentage of patients with severe lesions the study lacked statistical power. A strong posi-
tive correlation was found between the PP-scale, the Buruli Ulcer Functional Limitation Score
(BUFLS) and the Children’s Dermatology Life Quality Index (CDLQI) confirming construct
validity. Although discriminative power of the scale was highly significant, the median differ-
ence of 1-point sum score is small and raises questions about the clinical relevance of this
difference.
Participants with category III lesions or with joints involved scored slightly higher on the
PP-scale. These differences suggest that physical limitations limit social participation. How-
ever, the difference related to joint involvement was small and statistically non-significant. We
cannot exclude this difference to have arisen by chance. It is also possible that the scale is not
sensitive in measuring smaller barriers related to physical limitations. The study by the Zeeuw
et al. on the psychometric properties of the P-scale among adults found higher participation
restrictions among patients with visible deformities and/or joint involvement [12].
While most patients in Ghana went to school, in Benin only 56% went to school after treat-
ment. Reasons for drop-out were directly related to their disease such as functional limitation
or stigma, or the result of indirect consequences such as expectations of (financial) compensa-
tion for their absence. However, it is difficult differentiate between indirect consequences of
BU and more general socio-economic circumstances as poverty or other responsibilities.
In total, scores of 32 participants were reassessed. Based on these reliability measures, the
smallest detectable change (SDC) is much larger than the minimal important change (MIC).
The a priori set level of 50 participants as minimum to test validity could not be met and this
should be further analysed by follow-up studies on the PP-scale.
The individual test scores are in line with previously reported problems among BU patients
[8,9]. Among children, school-drop out is the major problem, especially in Benin. Other major
problems are related to sports, ability to attend religious ceremonies and having friends (S4
Appendix). Former BU patients in Benin score substantially higher on most of the items of the
PP-scale compared to the former patients in Ghana. The observed differences in participation
restrictions, mostly related to sports and social activities, could be related to differences in
socio-economic conditions and treatment outcomes (i.e. severity of lesions) between Ghana
and Benin. Sociocultural differences may also have led to a different pattern in answering.
Patients in Benin on average have more severe lesions than patients in Ghana, which makes it
more likely that the detected differences actually reflect differences in disease outcome.
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The instrument we developed was well-received by the participants and their guardians.
Most of the participants were able to answer all the questions and they did not report questions
being too sensitive. The procedure took approximately 20 minutes and most participants were
able to pay attention until the end. Among younger participants, parents were often involved
in answering the questions.
Measuring participation restrictions in children is challenging and studies on participation
in children with disabilities in low-income settings are scant. Social participation among chil-
dren is influenced by different factors, including socio-economic status, physical abilities, and
community perception of the disease and related stigma. A study from southern Ethiopia in
children with scabies and tungiasis reports a moderate impact of the disease on their quality of
life, especially the ability to go to school due to physical barriers [18]. A study in South Africa
and Malawi describes absence of school due to HIV related stigma and poor living conditions
as major determinants of participation restrictions among HIV infected children [19].
In contrast, a study on quality of life in adults with leprosy shows that the incapacity to con-
tribute to the family finances–and not the physical impairments—is a major driver of disease
related stigma [20]. It is possible that former paediatric BU patients in this study face similar
problems as a result of the indirect barriers (e.g. inability to contribute financially) related to
the disease.
This study has several limitations. A major limitation was the limited ability to test validity.
The defined hypotheses were based on the underlying assumption that most of the patients
had moderate to severe (category II/III) lesions. However, due to the improvements in diagno-
sis and treatment, most of the patients in Ghana had category I lesions. This resulted in weaker
associations based on the predefined hypothesis. Correspondingly, we found a floor effect
where 70% of the former patients in Ghana scored 0 on the PP-scale. Therefore, to reach statis-
tically significant results with regard to the a priori set hypotheses, a bigger sample size (or a
sample of patients with more severe forms of the disease) would be needed or hypotheses
should be changed based on more mild forms of BU. The low score of participation restric-
tions among patients from Ghana correspondents with findings of a good quality of life
among former BU patients with small lesions, as a result of improvements in early identifica-
tion and treatment of BU patients in Ghana [21].
The interview setting, which was unusual for many participants, may have influenced the
answers of the participants. In many cases parents or other family members were involved in
answering the questions, especially among the younger children, which could have influenced
the answers of the participants. A relatively small proportion of the study participants were
aged between 5–8 years, due to both the study design (late follow-up compared to patient iden-
tification) and the lower prevalence of BU among the younger children. Finally, the questions
were formulated in French and translated to either Twi or Fon on spot, which could result in
variations in translation. However, during data collection regular meetings with the translators
and local health care professionals involved in the study were organized to discuss the process
of the interviews, including the importance of continuing to use the exact same wording dur-
ing the interviews. The same translators were used during the entire study period. Despite
these limitations, this is the first research that provides an indication that former BU patients
under 15-years of age may face participation restrictions in important aspects of their lives.
Participation restrictions that former patients face limits future possibilities and reduces
quality of life of the individual patient. Early detection of cases and information about the dis-
ease is important to prevent social exclusion. As seen in Ghana, early case detection and
improvement of treatment has large impact on improving the quality of life and participation
of former patients, and this is the major factor that reduces participation restrictions. In addi-
tion, programs to improve participation of former patients in the community should be
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considered, similar to the existing programs for leprosy and HIV. These programs have proven
to reduce stigma and social exclusion among leprosy patients [22,23]. Increasing our knowl-
edge about participation problems may improve participation opportunities among former
Buruli Ulcer paediatric patients. An instrument such as the PP-scale, when further tested and
validated, could be a useful tool to identify major barriers former BU patients face, and may
help local health service providers to better meet the needs of the patients.
The preliminary results of the PP-scale validation are promising. The instrument may well
be valid to measure participation restrictions among children with more severe forms of BU,
but future additional validation studies need to confirm this.
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